Figure 7From: Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition DS/Cu restores the expression of Nrf2 and P65 while activating JNK pathway in vivo. Representative western blots analysis of tumor tissue extracts with antibodies against Nrf2, P65 and c-jun.Back to article page